Nanchang Baiji Pharmaceutical

Company Drug

Nanchang Baiji Pharmaceutical’s Budesonide Nasal Spray Approved by China’s NMPA

Fineline Cube Dec 5, 2023

Nanchang Baiji Pharmaceutical Co. Ltd., a Chinese pharmaceutical company, has received approval from the National...

Company Drug

BMS Faces Phase III Setback for Camzyos in Non-Obstructive HCM Study

Company Drug

Beijing Wantai Launches Phase III Trial for 9-Valent HPV Vaccine in Chinese Males

Company Drug

Jiangsu Nhwa Initiates Phase I Trial for NH280105, an Oral Lp-PLA₂ Inhibitor for Alzheimer’s Disease

Company Drug

Hengrui Pharmaceuticals Gains NMPA Clearance for Phase II Study of HRS-7058 in Solid Tumors